Adjuvant therapy for stage IIB + IIC melanoma Editorial
| Authors: | Malekzadeh, P.; Brady, M. S. |
| Title: | Adjuvant therapy for stage IIB + IIC melanoma |
| Keywords: | cancer survival; overall survival; drug efficacy; drug safety; multimodality cancer therapy; cancer adjuvant therapy; combined modality therapy; cancer staging; recurrence risk; neoplasm staging; cancer immunotherapy; melanoma; skin neoplasms; editorial; practice guideline; pathology; skin tumor; b raf kinase inhibitor; molecularly targeted therapy; vemurafenib; mitogen activated protein kinase kinase inhibitor; cancer prognosis; nivolumab; humans; human; pembrolizumab |
| Journal Title: | Journal of Surgical Oncology |
| Volume: | 129 |
| Issue: | 1 |
| ISSN: | 0022-4790 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2024-01-01 |
| Start Page: | 91 |
| End Page: | 96 |
| Language: | English |
| DOI: | 10.1002/jso.27534 |
| PUBMED: | 38031847 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Editorial -- Source: Scopus |
